Antenatal dexamethasone for early preterm birth in low-resource countries
- Autores
- Oladapo, Olufemi T.; Vogel, Joshua P.; Piaggio, Gilda; Nguyen, My-Huong; Althabe, Fernando; Metin Gülmezoglu, A.; Bahl, Rajiv; Rao, Suman P.N.; de Costa, Ayesha; Gupta, Shuchita; Shahidullah, Mohammod; Chowdhury, Saleha B.; Ara, Gulshan; Akter, Shaheen; Akhter, Nasreen; Dey, Probhat R.; Abdus Sabur, M.; Azad, Mohammad T.; Choudhury, Shahana F.; Matin, M.A.; Goudar, Shivaprasad S.; Dhaded, Sangappa M.; Metgud, Mrityunjay C.; Pujar, Yeshita V.; Somannavar, Manjunath S.; Vernekar, Sunil S.; Herekar, Veena R.; Bidri, Shailaja R.; Mathapati, Sangamesh S.; Patil, Preeti G.; Patil, Mallanagouda M.; Gudadinni, Muttappa R.; Bijapure, Hidaytullah R.; Mallapur, Ashalata A.; Katageri, Geetanjali M.; Chikkamath, Sumangala B.; Yelamali, Bhuvaneshwari C.; Pol, Ramesh R.; Misra, Sujata S.; Das, Leena
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- BACKGROUND: The safety and efficacy of antenatal glucocorticoids in women in low-resource countries who are at risk for preterm birth are uncertain. METHODS: We conducted a multicountry, randomized trial involving pregnant women between 26 weeks 0 days and 33 weeks 6 days of gestation who were at risk for preterm birth. The participants were assigned to intramuscular dexamethasone or identical placebo. The primary outcomes were neonatal death alone, stillbirth or neonatal death, and possible maternal bacterial infection; neonatal death alone and stillbirth or neonatal death were evaluated with superiority analyses, and possible maternal bacterial infection was evaluated with a noninferiority analysis with the use of a prespecified margin of 1.25 on the relative scale. RESULTS: A total of 2852 women (and their 3070 fetuses) from 29 secondary- and tertiary-level hospitals across Bangladesh, India, Kenya, Nigeria, and Pakistan underwent randomization. The trial was stopped for benefit at the second interim analysis. Neonatal death occurred in 278 of 1417 infants (19.6%) in the dexamethasone group and in 331 of 1406 infants (23.5%) in the placebo group (relative risk, 0.84; 95% confidence interval [CI], 0.72 to 0.97; P=0.03). Stillbirth or neonatal death occurred in 393 of 1532 fetuses and infants (25.7%) and in 444 of 1519 fetuses and infants (29.2%), respectively (relative risk, 0.88; 95% CI, 0.78 to 0.99; P=0.04); the incidence of possible maternal bacterial infection was 4.8% and 6.3%, respectively (relative risk, 0.76; 95% CI, 0.56 to 1.03). There was no significant between-group difference in the incidence of adverse events. CONCLUSIONS: Among women in low-resource countries who were at risk for early preterm birth, the use of dexamethasone resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an increase in the incidence of possible maternal bacterial infection.
Fil: Oladapo, Olufemi T.. Organizacion Mundial de la Salud; Argentina
Fil: Vogel, Joshua P.. Organizacion Mundial de la Salud; Argentina
Fil: Piaggio, Gilda. Organizacion Mundial de la Salud; Argentina
Fil: Nguyen, My-Huong. Organizacion Mundial de la Salud; Argentina
Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Metin Gülmezoglu, A.. Organizacion Mundial de la Salud; Argentina
Fil: Bahl, Rajiv. Organizacion Mundial de la Salud; Argentina
Fil: Rao, Suman P.N.. Organizacion Mundial de la Salud; Argentina
Fil: de Costa, Ayesha. Organizacion Mundial de la Salud; Argentina
Fil: Gupta, Shuchita. Organizacion Mundial de la Salud; Argentina
Fil: Shahidullah, Mohammod. No especifíca;
Fil: Chowdhury, Saleha B.. No especifíca;
Fil: Ara, Gulshan. No especifíca;
Fil: Akter, Shaheen. No especifíca;
Fil: Akhter, Nasreen. No especifíca;
Fil: Dey, Probhat R.. No especifíca;
Fil: Abdus Sabur, M.. No especifíca;
Fil: Azad, Mohammad T.. No especifíca;
Fil: Choudhury, Shahana F.. No especifíca;
Fil: Matin, M.A.. No especifíca;
Fil: Goudar, Shivaprasad S.. No especifíca;
Fil: Dhaded, Sangappa M.. No especifíca;
Fil: Metgud, Mrityunjay C.. No especifíca;
Fil: Pujar, Yeshita V.. No especifíca;
Fil: Somannavar, Manjunath S.. No especifíca;
Fil: Vernekar, Sunil S.. No especifíca;
Fil: Herekar, Veena R.. No especifíca;
Fil: Bidri, Shailaja R.. No especifíca;
Fil: Mathapati, Sangamesh S.. No especifíca;
Fil: Patil, Preeti G.. No especifíca;
Fil: Patil, Mallanagouda M.. No especifíca;
Fil: Gudadinni, Muttappa R.. No especifíca;
Fil: Bijapure, Hidaytullah R.. No especifíca;
Fil: Mallapur, Ashalata A.. No especifíca;
Fil: Katageri, Geetanjali M.. No especifíca;
Fil: Chikkamath, Sumangala B.. No especifíca;
Fil: Yelamali, Bhuvaneshwari C.. No especifíca;
Fil: Pol, Ramesh R.. No especifíca;
Fil: Misra, Sujata S.. No especifíca;
Fil: Das, Leena. No especifíca; - Materia
-
Dexamethasone
Early preterm birth
Low-resource countries - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/142666
Ver los metadatos del registro completo
id |
CONICETDig_ce834963f5828cf7190ef2d9dbdbf0cd |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/142666 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Antenatal dexamethasone for early preterm birth in low-resource countriesOladapo, Olufemi T.Vogel, Joshua P.Piaggio, GildaNguyen, My-HuongAlthabe, FernandoMetin Gülmezoglu, A.Bahl, RajivRao, Suman P.N.de Costa, AyeshaGupta, ShuchitaShahidullah, MohammodChowdhury, Saleha B.Ara, GulshanAkter, ShaheenAkhter, NasreenDey, Probhat R.Abdus Sabur, M.Azad, Mohammad T.Choudhury, Shahana F.Matin, M.A.Goudar, Shivaprasad S.Dhaded, Sangappa M.Metgud, Mrityunjay C.Pujar, Yeshita V.Somannavar, Manjunath S.Vernekar, Sunil S.Herekar, Veena R.Bidri, Shailaja R.Mathapati, Sangamesh S.Patil, Preeti G.Patil, Mallanagouda M.Gudadinni, Muttappa R.Bijapure, Hidaytullah R.Mallapur, Ashalata A.Katageri, Geetanjali M.Chikkamath, Sumangala B.Yelamali, Bhuvaneshwari C.Pol, Ramesh R.Misra, Sujata S.Das, LeenaDexamethasoneEarly preterm birthLow-resource countrieshttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3BACKGROUND: The safety and efficacy of antenatal glucocorticoids in women in low-resource countries who are at risk for preterm birth are uncertain. METHODS: We conducted a multicountry, randomized trial involving pregnant women between 26 weeks 0 days and 33 weeks 6 days of gestation who were at risk for preterm birth. The participants were assigned to intramuscular dexamethasone or identical placebo. The primary outcomes were neonatal death alone, stillbirth or neonatal death, and possible maternal bacterial infection; neonatal death alone and stillbirth or neonatal death were evaluated with superiority analyses, and possible maternal bacterial infection was evaluated with a noninferiority analysis with the use of a prespecified margin of 1.25 on the relative scale. RESULTS: A total of 2852 women (and their 3070 fetuses) from 29 secondary- and tertiary-level hospitals across Bangladesh, India, Kenya, Nigeria, and Pakistan underwent randomization. The trial was stopped for benefit at the second interim analysis. Neonatal death occurred in 278 of 1417 infants (19.6%) in the dexamethasone group and in 331 of 1406 infants (23.5%) in the placebo group (relative risk, 0.84; 95% confidence interval [CI], 0.72 to 0.97; P=0.03). Stillbirth or neonatal death occurred in 393 of 1532 fetuses and infants (25.7%) and in 444 of 1519 fetuses and infants (29.2%), respectively (relative risk, 0.88; 95% CI, 0.78 to 0.99; P=0.04); the incidence of possible maternal bacterial infection was 4.8% and 6.3%, respectively (relative risk, 0.76; 95% CI, 0.56 to 1.03). There was no significant between-group difference in the incidence of adverse events. CONCLUSIONS: Among women in low-resource countries who were at risk for early preterm birth, the use of dexamethasone resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an increase in the incidence of possible maternal bacterial infection.Fil: Oladapo, Olufemi T.. Organizacion Mundial de la Salud; ArgentinaFil: Vogel, Joshua P.. Organizacion Mundial de la Salud; ArgentinaFil: Piaggio, Gilda. Organizacion Mundial de la Salud; ArgentinaFil: Nguyen, My-Huong. Organizacion Mundial de la Salud; ArgentinaFil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; ArgentinaFil: Metin Gülmezoglu, A.. Organizacion Mundial de la Salud; ArgentinaFil: Bahl, Rajiv. Organizacion Mundial de la Salud; ArgentinaFil: Rao, Suman P.N.. Organizacion Mundial de la Salud; ArgentinaFil: de Costa, Ayesha. Organizacion Mundial de la Salud; ArgentinaFil: Gupta, Shuchita. Organizacion Mundial de la Salud; ArgentinaFil: Shahidullah, Mohammod. No especifíca;Fil: Chowdhury, Saleha B.. No especifíca;Fil: Ara, Gulshan. No especifíca;Fil: Akter, Shaheen. No especifíca;Fil: Akhter, Nasreen. No especifíca;Fil: Dey, Probhat R.. No especifíca;Fil: Abdus Sabur, M.. No especifíca;Fil: Azad, Mohammad T.. No especifíca;Fil: Choudhury, Shahana F.. No especifíca;Fil: Matin, M.A.. No especifíca;Fil: Goudar, Shivaprasad S.. No especifíca;Fil: Dhaded, Sangappa M.. No especifíca;Fil: Metgud, Mrityunjay C.. No especifíca;Fil: Pujar, Yeshita V.. No especifíca;Fil: Somannavar, Manjunath S.. No especifíca;Fil: Vernekar, Sunil S.. No especifíca;Fil: Herekar, Veena R.. No especifíca;Fil: Bidri, Shailaja R.. No especifíca;Fil: Mathapati, Sangamesh S.. No especifíca;Fil: Patil, Preeti G.. No especifíca;Fil: Patil, Mallanagouda M.. No especifíca;Fil: Gudadinni, Muttappa R.. No especifíca;Fil: Bijapure, Hidaytullah R.. No especifíca;Fil: Mallapur, Ashalata A.. No especifíca;Fil: Katageri, Geetanjali M.. No especifíca;Fil: Chikkamath, Sumangala B.. No especifíca;Fil: Yelamali, Bhuvaneshwari C.. No especifíca;Fil: Pol, Ramesh R.. No especifíca;Fil: Misra, Sujata S.. No especifíca;Fil: Das, Leena. No especifíca;Massachusetts Medical Society2020-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/142666Oladapo, Olufemi T.; Vogel, Joshua P.; Piaggio, Gilda; Nguyen, My-Huong; Althabe, Fernando; et al.; Antenatal dexamethasone for early preterm birth in low-resource countries; Massachusetts Medical Society; New England Journal of Medicine; 383; 26; 12-2020; 2514-25250028-4793CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMoa2022398info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:53:02Zoai:ri.conicet.gov.ar:11336/142666instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:53:02.326CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Antenatal dexamethasone for early preterm birth in low-resource countries |
title |
Antenatal dexamethasone for early preterm birth in low-resource countries |
spellingShingle |
Antenatal dexamethasone for early preterm birth in low-resource countries Oladapo, Olufemi T. Dexamethasone Early preterm birth Low-resource countries |
title_short |
Antenatal dexamethasone for early preterm birth in low-resource countries |
title_full |
Antenatal dexamethasone for early preterm birth in low-resource countries |
title_fullStr |
Antenatal dexamethasone for early preterm birth in low-resource countries |
title_full_unstemmed |
Antenatal dexamethasone for early preterm birth in low-resource countries |
title_sort |
Antenatal dexamethasone for early preterm birth in low-resource countries |
dc.creator.none.fl_str_mv |
Oladapo, Olufemi T. Vogel, Joshua P. Piaggio, Gilda Nguyen, My-Huong Althabe, Fernando Metin Gülmezoglu, A. Bahl, Rajiv Rao, Suman P.N. de Costa, Ayesha Gupta, Shuchita Shahidullah, Mohammod Chowdhury, Saleha B. Ara, Gulshan Akter, Shaheen Akhter, Nasreen Dey, Probhat R. Abdus Sabur, M. Azad, Mohammad T. Choudhury, Shahana F. Matin, M.A. Goudar, Shivaprasad S. Dhaded, Sangappa M. Metgud, Mrityunjay C. Pujar, Yeshita V. Somannavar, Manjunath S. Vernekar, Sunil S. Herekar, Veena R. Bidri, Shailaja R. Mathapati, Sangamesh S. Patil, Preeti G. Patil, Mallanagouda M. Gudadinni, Muttappa R. Bijapure, Hidaytullah R. Mallapur, Ashalata A. Katageri, Geetanjali M. Chikkamath, Sumangala B. Yelamali, Bhuvaneshwari C. Pol, Ramesh R. Misra, Sujata S. Das, Leena |
author |
Oladapo, Olufemi T. |
author_facet |
Oladapo, Olufemi T. Vogel, Joshua P. Piaggio, Gilda Nguyen, My-Huong Althabe, Fernando Metin Gülmezoglu, A. Bahl, Rajiv Rao, Suman P.N. de Costa, Ayesha Gupta, Shuchita Shahidullah, Mohammod Chowdhury, Saleha B. Ara, Gulshan Akter, Shaheen Akhter, Nasreen Dey, Probhat R. Abdus Sabur, M. Azad, Mohammad T. Choudhury, Shahana F. Matin, M.A. Goudar, Shivaprasad S. Dhaded, Sangappa M. Metgud, Mrityunjay C. Pujar, Yeshita V. Somannavar, Manjunath S. Vernekar, Sunil S. Herekar, Veena R. Bidri, Shailaja R. Mathapati, Sangamesh S. Patil, Preeti G. Patil, Mallanagouda M. Gudadinni, Muttappa R. Bijapure, Hidaytullah R. Mallapur, Ashalata A. Katageri, Geetanjali M. Chikkamath, Sumangala B. Yelamali, Bhuvaneshwari C. Pol, Ramesh R. Misra, Sujata S. Das, Leena |
author_role |
author |
author2 |
Vogel, Joshua P. Piaggio, Gilda Nguyen, My-Huong Althabe, Fernando Metin Gülmezoglu, A. Bahl, Rajiv Rao, Suman P.N. de Costa, Ayesha Gupta, Shuchita Shahidullah, Mohammod Chowdhury, Saleha B. Ara, Gulshan Akter, Shaheen Akhter, Nasreen Dey, Probhat R. Abdus Sabur, M. Azad, Mohammad T. Choudhury, Shahana F. Matin, M.A. Goudar, Shivaprasad S. Dhaded, Sangappa M. Metgud, Mrityunjay C. Pujar, Yeshita V. Somannavar, Manjunath S. Vernekar, Sunil S. Herekar, Veena R. Bidri, Shailaja R. Mathapati, Sangamesh S. Patil, Preeti G. Patil, Mallanagouda M. Gudadinni, Muttappa R. Bijapure, Hidaytullah R. Mallapur, Ashalata A. Katageri, Geetanjali M. Chikkamath, Sumangala B. Yelamali, Bhuvaneshwari C. Pol, Ramesh R. Misra, Sujata S. Das, Leena |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Dexamethasone Early preterm birth Low-resource countries |
topic |
Dexamethasone Early preterm birth Low-resource countries |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
BACKGROUND: The safety and efficacy of antenatal glucocorticoids in women in low-resource countries who are at risk for preterm birth are uncertain. METHODS: We conducted a multicountry, randomized trial involving pregnant women between 26 weeks 0 days and 33 weeks 6 days of gestation who were at risk for preterm birth. The participants were assigned to intramuscular dexamethasone or identical placebo. The primary outcomes were neonatal death alone, stillbirth or neonatal death, and possible maternal bacterial infection; neonatal death alone and stillbirth or neonatal death were evaluated with superiority analyses, and possible maternal bacterial infection was evaluated with a noninferiority analysis with the use of a prespecified margin of 1.25 on the relative scale. RESULTS: A total of 2852 women (and their 3070 fetuses) from 29 secondary- and tertiary-level hospitals across Bangladesh, India, Kenya, Nigeria, and Pakistan underwent randomization. The trial was stopped for benefit at the second interim analysis. Neonatal death occurred in 278 of 1417 infants (19.6%) in the dexamethasone group and in 331 of 1406 infants (23.5%) in the placebo group (relative risk, 0.84; 95% confidence interval [CI], 0.72 to 0.97; P=0.03). Stillbirth or neonatal death occurred in 393 of 1532 fetuses and infants (25.7%) and in 444 of 1519 fetuses and infants (29.2%), respectively (relative risk, 0.88; 95% CI, 0.78 to 0.99; P=0.04); the incidence of possible maternal bacterial infection was 4.8% and 6.3%, respectively (relative risk, 0.76; 95% CI, 0.56 to 1.03). There was no significant between-group difference in the incidence of adverse events. CONCLUSIONS: Among women in low-resource countries who were at risk for early preterm birth, the use of dexamethasone resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an increase in the incidence of possible maternal bacterial infection. Fil: Oladapo, Olufemi T.. Organizacion Mundial de la Salud; Argentina Fil: Vogel, Joshua P.. Organizacion Mundial de la Salud; Argentina Fil: Piaggio, Gilda. Organizacion Mundial de la Salud; Argentina Fil: Nguyen, My-Huong. Organizacion Mundial de la Salud; Argentina Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina Fil: Metin Gülmezoglu, A.. Organizacion Mundial de la Salud; Argentina Fil: Bahl, Rajiv. Organizacion Mundial de la Salud; Argentina Fil: Rao, Suman P.N.. Organizacion Mundial de la Salud; Argentina Fil: de Costa, Ayesha. Organizacion Mundial de la Salud; Argentina Fil: Gupta, Shuchita. Organizacion Mundial de la Salud; Argentina Fil: Shahidullah, Mohammod. No especifíca; Fil: Chowdhury, Saleha B.. No especifíca; Fil: Ara, Gulshan. No especifíca; Fil: Akter, Shaheen. No especifíca; Fil: Akhter, Nasreen. No especifíca; Fil: Dey, Probhat R.. No especifíca; Fil: Abdus Sabur, M.. No especifíca; Fil: Azad, Mohammad T.. No especifíca; Fil: Choudhury, Shahana F.. No especifíca; Fil: Matin, M.A.. No especifíca; Fil: Goudar, Shivaprasad S.. No especifíca; Fil: Dhaded, Sangappa M.. No especifíca; Fil: Metgud, Mrityunjay C.. No especifíca; Fil: Pujar, Yeshita V.. No especifíca; Fil: Somannavar, Manjunath S.. No especifíca; Fil: Vernekar, Sunil S.. No especifíca; Fil: Herekar, Veena R.. No especifíca; Fil: Bidri, Shailaja R.. No especifíca; Fil: Mathapati, Sangamesh S.. No especifíca; Fil: Patil, Preeti G.. No especifíca; Fil: Patil, Mallanagouda M.. No especifíca; Fil: Gudadinni, Muttappa R.. No especifíca; Fil: Bijapure, Hidaytullah R.. No especifíca; Fil: Mallapur, Ashalata A.. No especifíca; Fil: Katageri, Geetanjali M.. No especifíca; Fil: Chikkamath, Sumangala B.. No especifíca; Fil: Yelamali, Bhuvaneshwari C.. No especifíca; Fil: Pol, Ramesh R.. No especifíca; Fil: Misra, Sujata S.. No especifíca; Fil: Das, Leena. No especifíca; |
description |
BACKGROUND: The safety and efficacy of antenatal glucocorticoids in women in low-resource countries who are at risk for preterm birth are uncertain. METHODS: We conducted a multicountry, randomized trial involving pregnant women between 26 weeks 0 days and 33 weeks 6 days of gestation who were at risk for preterm birth. The participants were assigned to intramuscular dexamethasone or identical placebo. The primary outcomes were neonatal death alone, stillbirth or neonatal death, and possible maternal bacterial infection; neonatal death alone and stillbirth or neonatal death were evaluated with superiority analyses, and possible maternal bacterial infection was evaluated with a noninferiority analysis with the use of a prespecified margin of 1.25 on the relative scale. RESULTS: A total of 2852 women (and their 3070 fetuses) from 29 secondary- and tertiary-level hospitals across Bangladesh, India, Kenya, Nigeria, and Pakistan underwent randomization. The trial was stopped for benefit at the second interim analysis. Neonatal death occurred in 278 of 1417 infants (19.6%) in the dexamethasone group and in 331 of 1406 infants (23.5%) in the placebo group (relative risk, 0.84; 95% confidence interval [CI], 0.72 to 0.97; P=0.03). Stillbirth or neonatal death occurred in 393 of 1532 fetuses and infants (25.7%) and in 444 of 1519 fetuses and infants (29.2%), respectively (relative risk, 0.88; 95% CI, 0.78 to 0.99; P=0.04); the incidence of possible maternal bacterial infection was 4.8% and 6.3%, respectively (relative risk, 0.76; 95% CI, 0.56 to 1.03). There was no significant between-group difference in the incidence of adverse events. CONCLUSIONS: Among women in low-resource countries who were at risk for early preterm birth, the use of dexamethasone resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an increase in the incidence of possible maternal bacterial infection. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/142666 Oladapo, Olufemi T.; Vogel, Joshua P.; Piaggio, Gilda; Nguyen, My-Huong; Althabe, Fernando; et al.; Antenatal dexamethasone for early preterm birth in low-resource countries; Massachusetts Medical Society; New England Journal of Medicine; 383; 26; 12-2020; 2514-2525 0028-4793 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/142666 |
identifier_str_mv |
Oladapo, Olufemi T.; Vogel, Joshua P.; Piaggio, Gilda; Nguyen, My-Huong; Althabe, Fernando; et al.; Antenatal dexamethasone for early preterm birth in low-resource countries; Massachusetts Medical Society; New England Journal of Medicine; 383; 26; 12-2020; 2514-2525 0028-4793 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMoa2022398 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Massachusetts Medical Society |
publisher.none.fl_str_mv |
Massachusetts Medical Society |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269197016498176 |
score |
13.13397 |